Cargando…
Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines
Gene silencing by small interfering RNA (siRNA) is useful for analyzing the functions of human immune cells. However, the transfection of siRNA to human immune cells is difficult. Here, we used a multifunctional envelope-type nanodevice (MEND) containing YSK12-C4 (YSK12-MEND) to efficiently introduc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124971/ https://www.ncbi.nlm.nih.gov/pubmed/27892533 http://dx.doi.org/10.1038/srep37849 |
_version_ | 1782469909445345280 |
---|---|
author | Nakamura, Takashi Kuroi, Moeka Fujiwara, Yuki Warashina, Shota Sato, Yusuke Harashima, Hideyoshi |
author_facet | Nakamura, Takashi Kuroi, Moeka Fujiwara, Yuki Warashina, Shota Sato, Yusuke Harashima, Hideyoshi |
author_sort | Nakamura, Takashi |
collection | PubMed |
description | Gene silencing by small interfering RNA (siRNA) is useful for analyzing the functions of human immune cells. However, the transfection of siRNA to human immune cells is difficult. Here, we used a multifunctional envelope-type nanodevice (MEND) containing YSK12-C4 (YSK12-MEND) to efficiently introduce siRNA to human immune cell lines, Jurkat, THP-1, KG-1 and NK92. The YSK12-MEND was transfected to human immune cell lines at a siRNA dose range of 1–30 nM, resulting that maximum gene silencing efficiencies at the mRNA level in Jurkat, THP-1, KG-1 and NK92 were 96%, 96%, 91% and 75%, respectively. The corresponding values for Lipofectamine RNAiMAX (RNAiMAX) were 37%, 56%, 43% and 19%, respectively. The process associated with cellular uptake played a role in effective gene silencing effect of the YSK12-MEND. The small size and high non-aggregability of the YSK12-MEND were advantageous for the cellular internalization of siRNA to immune cell lines. In the case of RNAiMAX, a drastic increase in particles size was observed in the medium used, which inhibited cellular uptake. The YSK12-MEND reported in herein appears to be appropriate for delivering siRNA to human immune cells, and the small particle size and non-aggregability are essential properties. |
format | Online Article Text |
id | pubmed-5124971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51249712016-12-08 Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines Nakamura, Takashi Kuroi, Moeka Fujiwara, Yuki Warashina, Shota Sato, Yusuke Harashima, Hideyoshi Sci Rep Article Gene silencing by small interfering RNA (siRNA) is useful for analyzing the functions of human immune cells. However, the transfection of siRNA to human immune cells is difficult. Here, we used a multifunctional envelope-type nanodevice (MEND) containing YSK12-C4 (YSK12-MEND) to efficiently introduce siRNA to human immune cell lines, Jurkat, THP-1, KG-1 and NK92. The YSK12-MEND was transfected to human immune cell lines at a siRNA dose range of 1–30 nM, resulting that maximum gene silencing efficiencies at the mRNA level in Jurkat, THP-1, KG-1 and NK92 were 96%, 96%, 91% and 75%, respectively. The corresponding values for Lipofectamine RNAiMAX (RNAiMAX) were 37%, 56%, 43% and 19%, respectively. The process associated with cellular uptake played a role in effective gene silencing effect of the YSK12-MEND. The small size and high non-aggregability of the YSK12-MEND were advantageous for the cellular internalization of siRNA to immune cell lines. In the case of RNAiMAX, a drastic increase in particles size was observed in the medium used, which inhibited cellular uptake. The YSK12-MEND reported in herein appears to be appropriate for delivering siRNA to human immune cells, and the small particle size and non-aggregability are essential properties. Nature Publishing Group 2016-11-28 /pmc/articles/PMC5124971/ /pubmed/27892533 http://dx.doi.org/10.1038/srep37849 Text en Copyright © 2016, The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Nakamura, Takashi Kuroi, Moeka Fujiwara, Yuki Warashina, Shota Sato, Yusuke Harashima, Hideyoshi Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines |
title | Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines |
title_full | Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines |
title_fullStr | Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines |
title_full_unstemmed | Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines |
title_short | Small-sized, stable lipid nanoparticle for the efficient delivery of siRNA to human immune cell lines |
title_sort | small-sized, stable lipid nanoparticle for the efficient delivery of sirna to human immune cell lines |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124971/ https://www.ncbi.nlm.nih.gov/pubmed/27892533 http://dx.doi.org/10.1038/srep37849 |
work_keys_str_mv | AT nakamuratakashi smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines AT kuroimoeka smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines AT fujiwarayuki smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines AT warashinashota smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines AT satoyusuke smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines AT harashimahideyoshi smallsizedstablelipidnanoparticlefortheefficientdeliveryofsirnatohumanimmunecelllines |